NewsFDA fast-tracks psychedelic drug research following Trump executive order Posted on April 24, 2026 by budd87309@gmail.com It’s a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said. budd87309@gmail.com Nato says US cannot suspend Spain from alliance, after reported Pentagon email – BBC Wall Street’s ‘fear gauge’ is doing something unusual. What it means
